These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17722576)

  • 1. [Nonsteroidal anti-inflammatory drugs. Declaration I. A study of interrelation "structure--the effectiveness of anti-inflammatory action"].
    Khaĭrullina VR; Mukhametov AD; Tiurina LA; Garifullina GG; Gerchikov AIa; Zarudiĭ FS
    Biomed Khim; 2007; 53(3):266-75. PubMed ID: 17722576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs).
    Dwivedi AK; Gurjar V; Kumar S; Singh N
    Drug Discov Today; 2015 Jul; 20(7):863-73. PubMed ID: 25794602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of mammalian cyclooxygenases.
    Garavito RM; Mulichak AM
    Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site?
    Soliva R; Almansa C; Kalko SG; Luque FJ; Orozco M
    J Med Chem; 2003 Apr; 46(8):1372-82. PubMed ID: 12672237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of nonsteroidal anti-inflammatory drugs with membranes: in vitro assessment and relevance for their biological actions.
    Pereira-Leite C; Nunes C; Reis S
    Prog Lipid Res; 2013 Oct; 52(4):571-84. PubMed ID: 23981364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights into cyclooxygenase irreversible inactivation by aspirin.
    Tosco P; Lazzarato L
    ChemMedChem; 2009 Jun; 4(6):939-45. PubMed ID: 19301318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspective assessment of COX-1 and COX-2 selectivity of nonsteroidal anti-inflammatory drugs from clinical practice: use of genetic function approximation.
    Zambre AP; Ganure AL; Shinde DB; Kulkarni VM
    J Chem Inf Model; 2007; 47(2):635-43. PubMed ID: 17256838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition.
    Geronikaki AA; Lagunin AA; Hadjipavlou-Litina DI; Eleftheriou PT; Filimonov DA; Poroikov VV; Alam I; Saxena AK
    J Med Chem; 2008 Mar; 51(6):1601-9. PubMed ID: 18311898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal anti-inflammatory drugs (NSAIDs): a comparative QSAR study.
    Michaelidou AS; Hadjipavlou-Litina D
    Chem Rev; 2005 Sep; 105(9):3235-71. PubMed ID: 16159152
    [No Abstract]   [Full Text] [Related]  

  • 10. Electronic-topological study of structurally diverse cyclooxygenase-2 inhibitors.
    Dimoglo A; Sim E; Shvets N; Ahsen V
    Mini Rev Med Chem; 2003 Jun; 3(4):281-94. PubMed ID: 12678822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs.
    Smith WL; DeWitt DL
    Semin Nephrol; 1995 May; 15(3):179-94. PubMed ID: 7631045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cox-2-selective inhibitors: the new super aspirins.
    DeWitt DL
    Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
    [No Abstract]   [Full Text] [Related]  

  • 13. A free energy based computational pathway from chemical templates to lead compounds: a case study of COX-2 inhibitors.
    Latha N; Jain T; Sharma P; Jayaram B
    J Biomol Struct Dyn; 2004 Jun; 21(6):791-804. PubMed ID: 15107001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromones: A Promising Ring System for New Anti-inflammatory Drugs.
    Silva CF; Pinto DC; Silva AM
    ChemMedChem; 2016 Oct; 11(20):2252-2260. PubMed ID: 27630077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
    Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
    Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprints.
    Hsu N; Cai D; Damodaran K; Gomez RF; Keck JG; Laborde E; Lum RT; Macke TJ; Martin G; Schow SR; Simon RJ; Villar HO; Wick MM; Beroza P
    J Med Chem; 2004 Sep; 47(20):4875-80. PubMed ID: 15369391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure activity relationship studies of diaryl furanones as selective COX-2 inhibitors.
    Shahapurkar S; Pandya T; Kawathekar N; Chaturvedi SC
    Eur J Med Chem; 2004 Apr; 39(4):383-8. PubMed ID: 15072847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computer simulation of the interaction of non-steroidal anti-inflammatory drugs: indoprofen and NS398 with cyclooxygenase.
    Kothekar V; Sahi S; Srinivasan M
    J Biomol Struct Dyn; 1999 Feb; 16(4):901-15. PubMed ID: 10217458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Research strategies for design and development of NSAIDs: clue to balance potency and toxicity of acetanilide compounds.
    Pal AK; Sen S; Ghosh S; Bera AK; Bhattacharya S; Chakraborty S; Banerjee A
    J Biomol Struct Dyn; 2001 Aug; 19(1):85-93. PubMed ID: 11565854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of indomethacin analogues that inhibit P-glycoprotein and/or multidrug resistant protein without COX inhibitory activity.
    Arisawa M; Kasaya Y; Obata T; Sasaki T; Nakamura T; Araki T; Yamamoto K; Sasaki A; Yamano A; Ito M; Abe H; Ito Y; Shuto S
    J Med Chem; 2012 Sep; 55(18):8152-63. PubMed ID: 22916727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.